Seeing Is Believing
Currently out of the existing stock ratings of Evan Wilson, 4 are a BUY (57.14%), 3 are a HOLD (42.86%).
Analyst Evan Wilson, currently employed carries an average stock price target met ratio of 87.96% that have a potential upside of 15.84% achieved within 335 days. Previously, Evan Wilson worked at KEYBANK.
Evan Wilson’s has documented 68 price targets and ratings displayed on 6 stocks. The coverage was on Communication Services, Healthcare, Technology sectors.
Most recent stock forecast was given on RPD, Rapid7 at 07-Nov-2023.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 4/11/2019. The price target of $135 was fulfilled within 6 days with a profit of $9.21 (6.39%) receiving and performance score of 10.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$95
$0.58 (0.61%)
$95.99
1 years 2 months 28 days ago
(22-Sep-2023)
0/4 (0%)
$1.08 (1.15%)
Hold
$95
$0.58 (0.61%)
$95
1 years 4 months 29 days ago
(21-Jul-2023)
15/20 (75%)
$4.07 (4.48%)
214
Hold
$90
$-4.42 (-4.68%)
$90
1 years 5 months ago
(20-Jul-2023)
7/11 (63.64%)
$-1.31 (-1.43%)
83
Hold
$96
$1.58 (1.67%)
$120
1 years 5 months ago
(20-Jul-2023)
10/14 (71.43%)
$4.69 (5.14%)
145
Buy
$96
$1.58 (1.67%)
$95
1 years 5 months ago
(20-Jul-2023)
2/6 (33.33%)
$4.69 (5.14%)
137
What Year was the first public recommendation made by Evan Wilson?